Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature-Reference-Cited by-同舟云学术

Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature

Published:2023-01-10 Issue:5 Volume:40 Page:506-515
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Castle Alison M. R.¹,Empringham Brianna²,Pinto Lisa M²,Villani Anita³,Kanwar Nisha⁴,Abbott Lesleigh S.²,Sawyer Sarah L¹⁵

Affiliation:

1. Department of Genetics, Children’s Hospital of Eastern Ontario (CHEO), Ottawa, Canada

2. Division of Hematology/Oncology, Department of Pediatrics, Children’s Hospital of Eastern Ontario (CHEO), Ottawa, Canada

3. Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada

4. Division of Genome Diagnostics, Department of Paediatric Laboratory Medicine and Pathobiology, The Hospital for Sick Children, Toronto, Canada

5. Children’s Hospital of Eastern Ontario (CHEO) Research Institute, University of Ottawa, Ottawa, Canada

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2022.2153951

Reference58 articles.

1. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

2. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1

3. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

4. Ries L, Smith M, Gurney J, et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: NIH Publisher; 1999.

5. Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irinotecan/vincristine;Reactions Weekly;2023-09-23